http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2008100039-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-12
filingDate 2006-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2009-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2008100039-A
titleOfInvention NEW SITE OF PHOSPHORILATION OF MITOGEN-ACTIVATED PROTEINKINASES, MODIFIED PROTEINS AND APPLICATION
abstract 1. MAPK protein selected from! a) a MAPK protein comprising a phosphorylated residue at a phosphorylation site that is different from a site or phosphorylation sites present in the activation segment of said MAPK protein, or a fragment of said protein including said phosphorylated residue, where! said different phosphorylation site is a threonine residue at position 123 (Thr123) p38 of a mouse, α-isoform, or a residue of a positionally equivalent amino acid sensitive to phosphorylation in another MAPK protein, as determined by multiple alignment of amino acid sequences, and! phosphorylation at said different phosphorylation site prevents the activation of said MAPK protein and also its activity towards its substrates; and! b) a MAPK protein comprising a negative charge or a bulk residue at a phosphorylation site or in a region surrounding said phosphorylation site that is different from a site or phosphorylation sites present in the activation segment of said MAPK protein or a fragment of said protein including said phosphorylated residue, where! said different phosphorylation site is a threonine residue at position 123 (Thr123) p38 of a mouse, α-isoform, or a residue of a positionally equivalent amino acid sensitive to phosphorylation in another MAPK protein, as determined by multiple alignment of amino acid sequences, and! the introduction of a negative charge or bulk residue in the specified phosphorylation site or in the region surrounding the specified phosphorylation site
priorityDate 2005-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33032
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6057
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP47809
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487901
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID26398
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6416
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419539584
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419488910
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID750
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397375
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537453
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5960
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5961
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397476
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP27638
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484026
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID41020
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP45985
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID841591
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO80397
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID145742
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397536

Total number of triples: 40.